Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)
0.9650
-0.0100 (-1.03%)
Last updated: May 12, 2025
FRA:TQR Revenue
In the year 2024, Beijing Tong Ren Tang Chinese Medicine Company had annual revenue of 1.61B HKD with 5.69% growth. Beijing Tong Ren Tang Chinese Medicine Company had revenue of 947.13M in the half year ending December 31, 2024, a decrease of -14.27%.
Revenue
1.61B HKD
Revenue Growth
+5.69%
P/S Ratio
4.09
Revenue / Employee
2.06M HKD
Employees
782
Market Cap
820.59M EUR
Revenue Chart
* This company reports financials in HKD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.61B | 86.70M | 5.69% |
Dec 31, 2023 | 1.52B | -206.15M | -11.91% |
Dec 31, 2022 | 1.73B | 174.94M | 11.24% |
Dec 31, 2021 | 1.56B | 240.81M | 18.31% |
Dec 31, 2020 | 1.32B | -117.29M | -8.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 76.54B |
Deutsche Telekom AG | 118.43B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Merck KGaA | 21.16B |